Sunday, September 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCB Insights

The AI agent market map

View original at cbinsights.com
CB Insights - Enterprise Ai Title: The AI agent market map Date: 2025-11-10 20:14 Source: https://www.cbinsights.com/research/ai-agent-market-map-2025/ <p>The AI agent moment is reshaping enterprise software.</p> <p>Since <a href="https://www.cbinsights.com/research/ai-agent-market-map/">our last mapping in March 2025<…
Opening lines of the source · CB Insights · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Horizontal AI agent startups outnumber verticalized solutions nearly 2-to-1 in the landscape.

    80% confidence
  • Agentic solutions have become a leading acquisition target for enterprise software incumbents.

    80% confidence
  • AI agent startups focused on cybersecurity operations are most primed to exit based on average CB Insights M&A probability scores.

    80% confidence
  • The private AI agent market is moving towards greater specialization, with industry-specific solutions surging since March 2025.

    80% confidence
  • Since March 2025, the AI agent landscape has exploded from roughly 300 players to thousands as tech companies race to launch AI agent offerings.

    80% confidence
  • AI-related cybersecurity M&A has already reached record levels in 2025.

    80% confidence
  • The healthcare and life sciences AI agent category grew from 7 companies in March 2025 to 47 companies in the November 2025 map iteration.

    80% confidence
  • Emerging startups are betting that highly regulated industries will favor specialized AI agent solutions over horizontal tools.

    80% confidence
  • 1 in 5 new unicorns ($1B+ valuation) are now developing AI agents.

    80% confidence
  • AI agents combine reasoning, memory, tool use, and planning capabilities.

    80% confidence
  • The software development AI agent market is the most crowded on the map, reflecting the value agents bring to well-defined workflows and testable environments.

    80% confidence
  • The coding AI agent market is facing challenges as reasoning models drive higher inference costs, previewing pricing pressures other agent categories will face.

    80% confidence
  • The top 20 AI agent revenue leaders average just 3.8 years old, with software development leading revenue activity featuring 6 coding agents.

    80% confidence
  • Nullify and Strike Ready top the cybersecurity acquisition probability list with 70%+ probability of getting acquired within the next two years.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com